News
Pharmaceutical maker Regeneron announced Monday it will buy genetic testing company 23andMe for $256 million following a bankruptcy auction. Regeneron said it will acquire 23andMe’s genomics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback